NCT06400914
Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere
Coopervision, Inc.·ClinicalTrials.gov·device·Device trialRecruitment Completed
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Ametropia
- Drug/Device/Intervention
- Lens A (ocufilcon D)
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- Coopervision, Inc.
- Location
- Mexico City, Mexico
Timeline & enrollment
- Phase
- N/A
- Start date
- Apr 02, 2024
- End date
- May 06, 2024
- Enrollment
- 40 participants
Primary outcome
Lens Fit Acceptance Ratings
Summary
The aim of this study is to compare the short-term clinical performance of two sphere contact
 lenses.
ICD-10 classifications
Amblyopia ex anopsiaAmoebiasisAmoebiasis, unspecifiedMyoclonusOesophagitis
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06400914
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for NCT06400914 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Recruitment Completed. The study focuses on Ametropia. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.